Table 2.
Effect of silver nanogel on excision wound model (percentage wound contraction) in albino Wistar rats.
| Groups | Days | |||
|---|---|---|---|---|
| 5th (% contraction) | 10th (% contraction) | 15th (% contraction) | 20th (% contraction) | |
| Group A | 33.22 ± 8.88 | 68.76 ± 21.95 | 87.14 ± 2.74 | 98.30 ±1.43 |
| Group B | 45.96 ± 8.66 | 69.10 ± 8.59 | 79.11 ± 10.59 | 94.23 ±6.65 |
| Group C | 38.06 ± 12.50 | 67.16 ± 17.81 | 79.88 ± 12.54 | 91.79 ± 10.77 |
| Group D | 29.70 ± 8.07 | 61.26 ± 11.18 | 80.38 ± 3.20 | 93.19 ± 4.53 |
| Group E | 14.32 ± 8.80 | 49.71 ± 15.83 | 84.76 ± 2.04 | 87.27 ± 3.64 |
| Group F | 27.42 ± 14.11 | 54.84 ± 8.87 | 80.31 ± 4.78 | 85.77 ± 7.45 |
Values (expressed in mean ± SD) tensile strength. Where, Group A: Test treatment group (Silver nanoparticles 0.1 mg g−1). Group B: Test treatment group (Silver nanoparticles 0.5 mg g−1). Group C: Test treatment group (Silver nanoparticles 1 mg g−1). Group D: Positive control (market drug silverex 0.2%). Group E: Group treated with gel base. Group F: Negative control (untreated group).
Bold values are of maximum contraction of wound as compared to other treatments.